(Total Views: 508)
Posted On: 03/18/2021 10:41:10 PM
Post# of 145247
![Avatar](https://investorshangout.com/images/ProfileImages/1227900469_64555_mark.jpg)
Re: ClosetInvestor #83578
Good call on the CEO's part.. FDA clearly was comfortable with discussing with him their feelings that Mild & Moderate patients didn't have a dire need for Leronlimab, and there were already approved treatments. Saved the company from a PR that Feuerstain and the rest of his turds would have had a field day with, and really underscores the communication channels CytoDyn has with the FDA.. if they don't like you, they just ignore you.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)